Premium Information is available for this item - Upgrade for $1 a day

6550-01-556-0939

Blood Grouping Test Reagent Set

6550015560939 015560939 342414

INC: 36693 Blood Grouping Test Reagent Set

6550-01-556-0939 REAGENT SET,BLOOD GROUPING TEST 6550015560939 015560939

Managed by United States
NSN Created on 24 Sep 2007
Data Last Changed
January 2023
NATO Update Count
1
NATO Data Quality
6550-01-556-0939 REAGENT SET,BLOOD GROUPING TEST 6550015560939 015560939 1/1
NSN 6550-01-556-0939 (Generic Image) 1/1

6550-01-556-0939 Stock and Availability Marketplace 6550-01-556-0939

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6550-01-556-0939 RQST NE eBay
eBay Updated Every Day
6550-01-556-0939 RQST eBay
Amazon Updated Every Day
6550-01-556-0939 RQST NE Amazon

6550-01-556-0939 Related Documents Related Documents 6550-01-556-0939 4+ Documents (More...)

6550-01-556-0939 4+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-556-0939
Blood Grouping Test Reagent Set 015560939 RQST NE Updated Every Day 6550-01-556-0939 RQST Updated Every
/fsg-65/fsc-6550/us 6550-01-556-0939 Blood Grouping Test Reagent Set 015560939 RQST NE Updated Every
5940-99-770-8953Quick Disconnect Terminal5940997708953 997708953 C342414 342875-2 AAU1246 153302-2 342414
www.nsnlookup.com /fsg-59/fsc-5940/uk 5940-99-770-8953 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-556-0939
Blood Grouping Test Reagent Set 015560939 Documents ( More... ) https//www.nsnlookup.com https/
5940251452697251452697,CD3,CD4 And Cd4 Monoclonal Antibodies https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-556-0939
Blood Grouping Test Reagent Set 015560939 Terminal Box 5940251452697251452697,CD3,CD4 And Grouping
Set 015423774 Cd3 And https ,CD4 013626248 Cd3 And Cd4 Monoclonal Antibodies https Datasheet 6550-01-556-0939
www.nsnlookup.com /fsg-59/fsc-5940/no 5940-25-145-2697 Terminal Box 5940251452697 251452697,CD3,CD4 Reagent Set 015560939

6550-01-556-0939 Demil Restrictions 6550-01-556-0939

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: A | ADPEC: 0

6550-01-556-0939 is a Blood Grouping Test Reagent Set that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6550-01-556-0939 HTS and ScheduleB Import and Export 6550-01-556-0939

6550-01-556-0939 End Users End Users 6550-01-556-0939

Turkey (ZW01)
Effective Date:
1 Sep 2007

6550-01-556-0939 Manufacturers Approved Sources 6550-01-556-0939

6550-01-556-0939 Technical Data Datasheet 6550-01-556-0939

Characteristic
Specifications
FIIG
A23800
Special Features [FEAT]
Bl Tritest Cd4 Fluorescein Isothiocyanate (Fitc)/Cd8 Phycoerythrin (Pe)/Cd3 Peridinin Chlorophyll Protein (Percp) Is A Three Color Direct Immunofluorescence Reagent For Use With A Flow Cytometer To Identify And Determine The Absolute Counts Of Mature Human T Lymphocytes (Cd3) Helper/Inducer (Cd3, Cd4) T Lymphocytes And Suppresor/Cytotoxic (Cd3,Cd8) T Lymphocytes In Erythrocyte-Lysed Whole Blood; When Used With Trucount Tubes Absolute Counts Of These Populations Can Be Enumerated From A Single Tube
Part Name Assigned By Controlling Agency [CXCY]
Tritest Cd4 Fitc/Cd8 Pe/Cd3 Per Cp Reagent

6550-01-556-0939 Similar Items Similar Supply Items to 6550-01-556-0939

6550-01-556-0939 Freight Data Freight Information 6550-01-556-0939

6550-01-556-0939 has freight characteristics managed by Turkey.. 6550-01-556-0939 has a variance between NMFC and UFC when transported by rail and the description should be consulted.